George  Netto, M.D.
George Netto, M.D.

Director of Surgical Pathology Molecular Diagnostics
Professor of Pathology, Urology and Oncology

Johns Hopkins University School of Medicine

Division of Surgical Pathology
Weinberg Building Room 2242
Baltimore, MD 21231 2410

Office: (410) 955-5082



Peer-reviewed Original Research Articles

  1. Netto GJ, Cheek JH, Zachariah NY, Romer JC, Lee CF, Schoenfeld R, Chakmakjian ZH. Steroid receptors in benign mastectomy tissue. Am J Clin Pathol 1990; 94:14-7.
  2. Urshel HC, Razzuk MA, Netto GJ, Disiere J, Chung SY. Sclerosing mediastinitis: improved management with histoplasmosis titer and ketoconazole. Ann Thorac Surg 1990; 50:215-21.
  3. Hagans JE, Harms SE, Pierce WB, Cheek JH, Flamig DP, Griffey RH, Savino DA, Netto GJ, et al.  MRI and breast cancer:  a new magnetic resonance technique specifically designed for the breast. Proc (Bayl Univ Med Cent) 1991; 16(4):17-20.
  4. Solomon H, Gonwa T, Mor E, Holman M, Gibbs J, Watemberg I, Netto G, Goldstein R, Husberg B, Klintmalm G. OKT3 rescue for steroid-resistant rejection in adult liver transplantation. Transplantation 1993; 55(1):87-91.
  5. Tong AW, Huang Y, Zhang B, Netto GJ, Vitetta E, Stone MJ. Heterotransplantation of human multiple myeloma cell lines in severe combined immunodefiency (SCID) mice. Anticancer Res 1993; 13(3):593-8.
  6. Harms SE, Flamig DP, Hesley KL, Evans WP, Cheek JH, Peters GN, Knox SM, Savino DA, Netto GJ, Wells R, Jones SE. Fat-suppressed three-dimensional MR imaging of the breast. Radiographics 1993; 13(2):247-267.
  7. Sarkis A, Bajorin D, Reuter V, Herr H, Netto G, Zhang Z-F, Schultz P, Cordon-Cardo C, Scher H. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. J Clin Oncol 1995; 13(6):1384-90.
  8. Mor E, Tillery  W, Solomon H, Netto G, Watemberg I, Klintmalm G. The predictive value of hepatocyte glycogen content on liver allograft biopsy. Correlation with early graft function. Transplantation 1995; 59(1):141-3.
  9. Scher H, Sarkis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Fuks Z, Mendelsohn J, Cordon-Cardo C. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Clin Cancer Res 1995; 1(5):545-50.
  10. Nord JD, Stolfi RL, Alfieri AA, Netto G, Reuter V, Sternberg SS, Colofiore JR, Koultcher JA, Martin DS. Apoptosis induced in advanced CD8F1- murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion. Cancer Chemother Pharmacol  1997; 40(5):376-84.
  11. Fabia R, Levy M, Crippin J, Tillery W, Netto G, Aguanno J, Dysert P, Goldstein R, Husberg B, Gonwa T, Klintmalm G. De Novo Hepatitis B infection after liver transplantation: source of disease, incidence, and impactLiver Transplant Surg 1998; 4(2):119-27.
  12. Testa G, Goldstein R, Netto G, Abbasoglu O, Jeyarajah R, Brooks B, Levy M, Husberg B, Gonwa T,  Klintmalm G.  Long-term outcome of patients transplanted with livers from Hepatitis C-positive donors. Transplantation 1998; 65(7):925-9.
  13. Travis D, Fabia R, Netto G, Husberg B, Goldstein R, Klintmalm G, Levy M.  Protection by cyclosporine A against normothermic liver ischemia-reperfusion in pigs. J Surg Res 1998;75(2):116-26.
  14. Jeyarajah D, Netto G, Lee SP, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein R, Gonwa TA, Tillery G, Crippin JS, Klintmalm GB.  Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation 1998; 66:1300-6.
  15. Bell D, Chomarat P, Broyles D, Netto G, Moumneh G, Lebecque S, Valladeau J, Davoust J, Palucka K,  Banchereau J. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999; 190(10):1417-25.
  16. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, Levy MF, Gonwa TA, Klintmalm GB. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 2000; 6(5):553-61.
  17. Tong AW, Seamour B, Chen J, Su D, Ordonez G, Frase L, Netto G, Stone MJ. CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells. Leuk Lymphoma. 2000; 36(5-6):543-58.
  18. Levy MF, Crippin J, Sutton S, Netto G, McCormack J, Curiel T, Goldstein RM, Newman JT, Gonwa TA, Banchereau J, Diamond LE, Byrne G, Logan J, Klintmalm GB. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation. 2000; 69:272-80.
  19. Högenauer C, Meyer RL, Netto GJ, Bell D, Little KH, Ferries L, Santa Ana CA, Porter JL, Fordtran JS.  Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I. N Engl J Med 2001; 344(4):270-4.
  20. Tong AW, Papayoti MH, Netto G, Armstrong DT, Ordonez G, Lawson JM, Stone MJ. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. Clin Cancer Res 2001; 7(3):691-703.
  21. Nemunaitis J, Cunningham C, Buchanan A, Edelman G, Maples P, Netto G, Tong A, Randlev B, Olson S, Kim D. Intravenous infusion of Replication-Selective (ONYX-15) in cancer patients: safety, feasibility and biological activity. Gene Ther 2001; 8(10):746-59.
  22. Melear JM, Goldstein RM, Levy MF, Molmenti EP, Cooper B, Netto GJ, Klintmalm GB, Stone MJ. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation 2002; 74(8):1090-5.
  23. Fasola CG, Netto GJ, Jennings LW, Christensen LL, Molmenti EP, Sanchez EQ, Levy MF, Goldstein RM, Klintmalm GB. Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil. Transplant Proc 2002; 34(5):1563-4.
  24. Fasola CG, Netto GJ, Christensen LL, Molmenti EP, Sanchez EQ, Levy MF, Goldstein RM, Klintmalm GB. Delay of hepatitis C recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction. Transplant Proc 2002; 34(5):1561-2.
  25. Molmenti EP, Netto GJ, Murray NG, Smith DM, Molmenti H, Crippin JS, Hoover TC, Jung G, Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Gonwa TA, Klintmalm GB. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl 2002; 8(6):519-26.
  26. Ganaraj A, Kuhn JA, Jones RC, Grant MD, Andrews VR, Knox SM, Netto GJ, Altrabulsi B, Livingston SA,  McCarty TM. Predictors for nonsentinel node involvement in breast cancer patients with micro-metastases in the sentinel lymph node. Proc (Bayl Univ Med Cent) 2003; 16(1):3-6.
  27. Smith D, Agura E, Netto G, Collins R, Molmenti E, Levy M, Goldstein R, Fasola C, Christensen L, Baker J, Altrabulsi B, Osowski L, McCormack J, Fichtel L, Dawson B, Domiati-Saad R, Stone M, Klintmalm G. Liver transplant associated graft versus host disease. Transplantation 2003; 75(1):118-26.
  28. Nemunaitis J, Cunningham C, Tong AW, Post L, Netto G, Paulson AS, Rich D, Blackburn A, Sands B, Gibson B, Randlev B, Freeman S. Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients. Cancer Gene Ther 2003; 10(5):341-52.
  29. Onaca NN, Levy MF, Netto GJ, Sanchez EQ, Chinnakotla S, Fasola C, Weinstein JS, Murray N, Goldstein RM, Klintmalam GB. Pretransplant MELD Score as a predictor of outcome after liver transplantation for chronic Hepatitis C. Am J of Transplant 2003; 3(5):626-30.
  30. Sanchez EQ, Levy MF, Goldstein RM, Fasola CG, Tillery GW, Netto GJ, Watkins DL, Weinstein JS, Murray NG, Byers D, Christensen LL, Klintmalm GB. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation 2003; 76(11):1583-8.
  31. Berenguer M, Crippin J, Gish R, Bass N, Bostrom A, Netto G, Alonzo J, Garcia-Kennedy R, Rayón JM, Wright TL. A model to predict severe HCV-related disease following live transplantation. Hepatology 2003; 38(1):34-41.
  32. Arenas JI, Gallegos-Orozco JF, Laskus T, Wilkinson J, Khatib A, Fasola C, Adair D, Radkowski M, Kibler KV, Nowicki M, Douglas D, Williams J, Netto G, Mulligan D, Klintmalm G, Rakela J, Vargas HE. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J Infect Dis 2004; 189(11):2037-46.
  33. Islas-Ohlmayer M, Padgett-Thomas A, Saad R, Melkus M, Cravens P. Martin M, Netto G, Garcia JV. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus. J Virol 2004; 78(24):13891-900.
  34. Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, Senzer N, Netto G, Rich D, Mhashilkar A, Parker K, Coffee K, Ramesh R, Ekmekcioglu S, Grimm EA, van Wart Hood J, Merritt J, Chada S. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther 2005; 11(1):160-72.
  35. Onaca N, Sanchez EQ, Melton LB, Netto GJ, Glastad KA, Martin PA, Ueno T, Levy MF, Goldstein RM, Klintmalm GB. Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria. Transplantation 2005; 80(3):421-4.
  36. May S, Netto G, Saad R, Kasper C. Cutaneous lymphoid hyperplasia and marginal zone B-cell lymphoma following vaccination: a study of two patients. J Am Acad Dermatol 2005; 53(3):512-516.
  37. Domiati-Saad R, Klintmalm G, Netto G, Agura ED, Chinnakotla S, Smith DM. Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism. Am J Transplant 2005; 5(12):2968-73
  38. Sanchez S, Holmes H, Katabi N, Newman J, Domiatti-Saad R, Stone M, Netto GJ.  Composite lymphocyte-rich Hodgkin lymphoma and peripheral T-cell lymphoma associated wih Epstein-Barr virus: a case report and review of the literature. Arch Pathol Lab Med 2006; 130(1):107-12.
  39. Netto GJ, Watkins DL, Williams JW, Colby T, dePetris G, Sharkey F, Corless C, Lewin D, Petrovic L, Sharma S, Kanel G, Theise N, West AB, Koehler A, Jhala N, Lefkowitch J, Lezzoni J, Jennings L, Tillery GW, Klintmalm, G, the Hepatitis C 3 Trial Group. Interobserver agreement in Hepatitis C grading and staging and Banff grading schema for acute cellular rejection: the “Hepatitis C 3” Multi-institutional trial experience. Arch Pathol Lab Med 2006; 130(8):1157-62.
  40. Netto GJ, Altrabulsi  B, Katabi N, Martin P, Burt K, Levy M, Sanchez E, Watkins DL, Jennings L, Klintmalm G, Goldstein R. Radio frequency ablation of hepatocellular carcinoma prior to liver transplantation: A histologic and ‘TUNEL’ study. Liver Int 2006; 26(6):746-71.
  41. Ueno T, Barri YM, Netto GJ, Martin A, Onaca N, Sanchez EQ, Chinnakotla S, Randall HB, Dawson S, Levy MF, Goldstein RM, Klintmalm GB. Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome. Transplantation. 2006; 82(4):501-7.
  42. Netto GJ, Epstein JI. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol 2006; 30(9):1184-8.
  43. Kuhn E, De Anda J, Manoni S, Netto GJ, Rosai J. Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: report of five cases and review of the literature. Am J Surg Pathol 2006; 30(11):1361-72.
  44. Martin AP, Goldstein RM, Dempster J, Netto GJ, Katabi N, Derrick HC, Altrabulsi B, Jennings LW, Ueno T, Chinnakotla S, Dawson S, Randall HB, Levy MF, Onaca N, Sanchez EQ, Orr D, Klintmalm GB. Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation - a clinical and histological examination. Clin Transplant 2006; 20(6):695-705.
  45. Chinnakotla S, Smith DM, Domiati-Saad R, Agura ED, Watkins DL, Netto GJ, Uemura T, Sanchez EQ, Levy M, Klintmalm G. Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management. Liver Transplant 2007; 13(1):157-61.
  46. Hansel DE, DeMarzo AM, Platz EA, Jadallah S, Hicks J, Epstein JI, Partin AW, and Netto GJ. Early prostate cancer antigen expression in predicting presence of prostate cancer among men with histologically negative biopsies. J Urol  2007; 177(5):1736-40.
  47. Owens C, Epstein JI and Netto GJ. Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry. Arch Pathol Lab Med 2007; 131(4):599-603.
  48. Gilliland GD, Gilliland G, Fincher T, Harrington J, Gilliland JM, Netto GJ, Burt K. Timing of return to normal activities after orbital floor fracture repair. Plast Reconstr Surg 2007; 120(1):245-51.
  49. Paulson KE, Rieger-Christ K, McDevitt MA, Kuperwasser C, Kim J, Unanue VE, Zhang X, Hu M, Ruthazer R, Berasi SP, Huang CY, Giri D, Kaufman S, Dugan JM, Blum J, Netto G, Wazer DE, Summerhayes IC, Yee AS. Alterations of the HBP1 Transcriptional Repressor are associated with invasive breast cancer. Cancer Res 2007; 67(13):6136-45.
  50. Klintmalm GB, Washburn WK, Rudich SM, Heffron TG, Teperman LW, Fasola C, Eckhoff DE, Netto GJ, Katz E. Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study. Liver Transpl 2007; 13(11):1521-31.
  51. Grosso JF, Kelleher CC, Timothy J. HarrisTJ, Maris CH, Hipkiss EL, DeMarzo A, Anders R,  Netto GJ, Getnet D, Bruno TB, Goldberg MV, Pardoll DM, Drake CG. LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. J Clin Invest 2007; 117(11):3383-92.
  52. Osunkoya AO, Netto GJ, Epstein JI. Colorectal adenocarcinoma involving the prostate: report of 9 cases. Hum Pathol 2007; 38(12):1836-41.
  53. Lane Z, Epstein JI, Ayub S, Netto GJ. Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features. Hum Pathol 2008; 39(4):543-9.
  54. Osunkoya AO, Hansel DE, Sun X, Netto GJ, Epstein JI. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases. Am J Surg Pathol 2008; 32(3):461-7.
  55. Sireci AN, Rodriguez R, Swierczynski SL, Netto GJ, Argani, P.  Fat-predominant mixed epithelial stromal tumor (MEST):  report of a unique case mimicking angiomyolipoma.  Int J Surg Pathol 2008; 16(1):73-7.
  56. Nagpal JK, Dasgupta S, Jadallah S, Chae YK, Ratovitski EA, Toubaji A, Netto GJ, Eagle T, Nissan A, Sidransky D, Trink B. Profiling the expression pattern of GPI transamidase complex subunits in human cancer. Mod Pathol 2008; 21(8):979-91.
  57. Loyo M, Pai SI, Netto GJ, Tunkel DE. Aggressive recurrent respiratory papillomatosis in a neonate. Int J Pediatr Otorhinolaryngol 2008; 72(6):917-20.
  58. Argani P, Netto GJ, Parwani AV. Papillary renal cell carcinoma with low-grade spindle cell foci: a mimic of mucinous tubular and spindle cell carcinoma. Am J Surg Pathol. 2008; 32(9):1353-9.
  59. Goodwin AC, Jadallah S, Toubaji A, Lecksell K, Hicks J, Kowalski J, Bova GS, De Marzo AM, Netto GJ, Casero RA Jr. Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. Prostate 2008; 68(7):766-72.
  60. Netto GJ, Nakai Y, Nakayama M, Jadallah S, Toubaji A, Nonomura N, Albadine R, Hicks J, Epstein JI, Yegnasubramanian S, Nelson WG, and De Marzo AM. Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in non-seminomatous male germ cell tumors. Mod Pathol 2008; 21(11):1337-44.
  61. Klock C, Gomes R, João M, Netto GJ. Prostate melanosis associated with acinar adenocarcinoma. Int J Surg Pathol 2008; Dec 18. [Epub ahead of print]
  62. Cheung WL, Albadine R, Chan T, Sharma R, Netto GJ. Phosphorylated H2AX in non-invasive low grade urothelial carcinoma of urinary bladder: Correlation with tumor recurrence. J Urol 2009; 181(3):1387-92.
  63. Lotan TL, Toubaji A, Albadine R, Latour M, Herawi M, Meeker AK, DeMarzo AM, Platz EA, Epstein JI, Netto GJ. TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas. Mod Pathol 2009; 22(3):359-65.
  64. Margulis V, Lotan Y, Karakiewicz PI, Fradet Y, Ashfaq R, Capitanio U, MontorsiF, Bastian PJ, Nielsen ME, Müller SC, Rigaud J, Heukamp LC, Netto G, Lerner SP, Sagalowsky AI, Shariat SF. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J Natl Cancer Inst 2009; 101(2):114-9.
  65. Albadine R, Wang W, Brownlee NA, Toubaji A, Billis A, Epstein JI, Argani P, Garvin AJ, Couzi, R, Schaeffer E, Pavlovich CP, Netto GJ. Topoisomerase IIA status in renal medullary carcinoma: immunoexpression and gene copy alterations of a potential target of therapy. J Urol 2009; 182(2):735-40.
  66. Wang W, Tavora F, Sharma R, Eisenberger M and Netto GJ. PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma. Urol Oncol 2009; 27(5):525-8.
  67. Fujita K, Pavlovich CP, Netto GJ, Konishi Y, Isaacs WB, Ali S, De Marzo AM, Meeker AK. Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology. Hum Pathol 2009; 40(7):924-33.
  68. Martignoni G, Pea M, Gobbo S, Brunelli M, Bonetti F, Segala D, Pan CC, Netto G, Doglioni C, Hes O, Argani P, Chilosi M. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol 2009; 22(8):1016-22.
  69. Osunkoya AO, Young AN, Wang W, Netto GJ, Epstein JI. Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney. Am J Surg Pathol 2009; 33(7):1103-6.
  70. Wada S, Yoshimura K, Hipkiss EL, Harris TJ, Yen HR, Goldberg MV, Grosso JF, Getnet D, Demarzo AM, Netto GJ, Anders R, Pardoll DM, Drake CG. Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model. Cancer Res 2009; 9(10):4309-18.
  71. Shariat SF, Lotan Y, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ,Nielsen ME, Capitanio U, Jeldres C, Montorsi F, Müller SC, Karam JA, Heukamp LC, Netto G, Lerner SP, Sagalowsky AI, Cote RJ. p53 predictive value for pT1-2 N0 disease at radical cystectomy. J Urol 2009; 182(3):907-13.
  72. Albadine R, Latour M, Toubaji A, Haffner M, Isaacs WB, A Platz E, Meeker AK, Demarzo AM, Epstein JI, Netto GJ. TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma. Mod Pathol 2009; 22(11):1415-22.
  73. Leman ES, Magheli A, Yong KM, Netto G, Hinz S, Getzenberg RH. Identification of nuclear structural protein alterations associated with seminomas. J Cell Biochem 2009; 108(6):1274-9.
  74. Verheul HM, van Erp K, Homs MY, Yoon GS, van Der Groep P, Rogers C, Hansel DE, Netto GJ, Pili R. The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma. Urology 2010; 75(3):608-14.
  75. D'Antonio KB, Toubaji A, Albadine R, Mondul AM, Platz EA, Netto GJ, Getzenberg RH. Extracellular matrix associated protein CYR61 is linked to prostate cancer development. J Urol 2010; 183(4):1604-10.
  76. Lee TK, Chuang ST, Netto GJ. Conventional prostatic adenocarcinoma arising in a multilocular prostatic cystadenoma. Pathol Int 2010; 60(5):413-6.
  77. Albadine R, Schultz L, Illei P, Ertoy D, Hicks J, Sharma R, Epstein JI, Netto GJ. PAX8 (+)/p63 (-) Immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol 2010; 34(7):965-9.
  78. Miyamoto H, Brimo F, Schultz L, Ye H, Miller JS, Fajardo D, Lee T, Epstein JI, Netto GJ. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a Post-WHO/ISUP Classification Cohort from a single academic center. Arch Pathol Lab Med 2010; 134(8):1160-3.
  79. Hammers HJ, Verheul HM, Salumbides B, Sharma R, Rudek M, Jaspers J, Shah P, Ellis L, Shen L, Paesante S, Dykema K, Furge K, Teh BT, Netto G, Pili R. Reversible epithelial to mesenchymal transition and acquired resistance to Sunitinib in patients with renal cell carcinoma: evidence from a Xenograft study. Mol CancerTher 2010;9(6):1525-35.
  80. Armstrong AJ, Netto GJ, Rudek MA, Halabi S, Wood DP, Creel PA, Mundy K, Davis SL, Wang T, Albadine R, Schultz L, Partin AW, Jimeno A, Fedor H, Febbo PG, George DJ, Gurganus R, De Marzo AM, Carducci MA. A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer. Clin Cancer Res 2010; 16(11):3057-66.
  81. Schaeffer EM, Guzzo TJ, Furge KA, Netto G, Westphal M, Dykema K, Yang X, Zhou M, Teh BT, Pavlovich CP. Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy. BJU Int 2010; Jul;106(1):62-5.
  82. Schultz L, Albadine R, Hicks J, Jadallah S, DeMarzo AM, Chen Y-B,Neilsen ME, Gonzalgo ML, Sidransky D, Schoenberg M, Netto GJ.  Expression status and prognostic significance of mTOR pathway members in urothelial carcinoma of urinary bladder following cystectomy. Cancer 2010; Dec 1;116(23):5517-26.
  83. Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho H, Dogan S, Ladanyi M, Martignoni G, Weiss SW. A distinctive subset of pecomas harbors TFE3 gene fusions.  Am J Surg Pathol 2010; Oct;34(10):1395-406.
  84. Argani P, Hicks J, De Marzo AM, Albadine R, Illei PB, Ladanyi M, Reuter VE and Netto GJ. Xp11 Translocation renal cell carcinoma (RCC):  extended immunohistochemical profile emphasizing novel RCC markers. Am J Surg Pathol 2010; Sep;34(9):1295-303.
  85. Netto GJ, Eisenberger M, Epstein JI; TAX 3501 Trial Investigators. Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial. Urology 2010; May;77(5):1155-60.
  86. Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, Gurel B, Isaacs WB, Bova GS, Liu W, Xu J, Meeker AK, Netto G, De Marzo AM, Nelson WG,Yegnasubramanian S. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet 2010;42(8):668-75.
  87. Magheli A, Gonzalgo ML, Su LM, Guzzo TJ, Netto G, Humphreys EB, Han M, Partin AW, Pavlovich CP. Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching. BJU Int 2011; Jun;107(12):1956-62.
  88. Sidana A, Wang M, Chowdhury WH, Toubaji A, Shabbeer S, Netto G, Carducci M, Lupold SE, Rodriguez R. Does valproic acid induce neuroendocrine differentiation in prostate cancer? J Biomed Biotechnol 2011; 607480.
  89. Ellis C, Banerjee P, Carney E, Sharma R and Netto GJ.  Adrenal Lymphangioma: clinicopathologic and immunohistochemical characteristics of a rare lesion. Hum Pathol 2011; Jul;42(7):1013-8. Epub 2011 Feb 11.
  90. Carney E, Banerjee P, Ellis CL, Albadine R, Sharma R, Burger P , Chaux A and Netto GJ. PAX2(-)/PAX8(-)/Inhibin A(+) immunoprofile in hemangioblastoma: a helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system. Am J Surg Pathol 2011;35(2):262-267.
  91. D'Antonio KB, Schultz L, Albadine R, Mondul AM, Platz EA, Netto GJ, Getzenberg RH. Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment. Clin Cancer Res 2010; 16(23):5908-5913.
  92. LeBron C, Pal P, Brait M, Dasgupta S, Guerrero-Preston R, Looijenga LH, Kowalski J, Netto G, Hoque MO. Genome-wide analysis of genetic alterations in testicular primary seminoma using high resolution single nucleotide polymorphism arrays. Genomics 2011; Jun;97(6):341-9.
  93. Wang H, Albadine R, Magheli A, Guzzo TJ, Ball MW, Hinz S, Schoenberg MP, Netto GJ, Gonzalgo ML. Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder. Urol Oncol 2011 Mar 9. [Epub ahead of print]
  94. Chaux A, Pfannl R, Rodríguez IM, Barreto JE, Velazquez EF, Lezcano C, Piris A, Netto GJ, Cubilla AL. Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases. Am J Surg Pathol 2011; Apr;35(4):553-62.
  95. Lotan TL, Gupta NS, Wang W, Toubaji A, Haffner MC, Chaux A, Hicks JL, Meeker AK, Bieberich CJ, De Marzo AM, Epstein JI, Netto GJ. ERG gene rearrangements are common in prostatic small cell carcinomas. Mod Pathol 2011; Jun;24(6)820-8.
  96. Cimino-Mathews A, Sharma R, Netto GJ. Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid. Am J Surg Pathol 2011; May;35(5):757-61.
  97. Brimo F, Herawi M, Sharma R, Netto GJ, Epstein JI, Illei PB. Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis. Hum Pathol 2011; Nov;42(11):1613-9.
  98. Ling S, Chang X, Schultz L, Lee TK, Chaux A, Marchionni L, Netto GJ, Sidransky D, Berman DM. An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. Cancer Res 2011; Jun;71(11):38212-21.
  99. Martignoni G, Gobbo S, Camparo P, Brunelli M, Munari E, Segala D, Pea M, Bonetti F, Illei PB, Netto GJ, Ladanyi M, Chilosi M, Argani P. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod Pathol 2011; Oct;24(10):1313-9.
  100. Elwood H, Chaux A, Schultz L, Illei PB, Baydar DE, Billis A, Sharma R, Argani P, Epstein JI, Netto GJ. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma. Urology 2011; Aug;78(2):474.e1-5.
  101. Chaux A, Albadine R, Toubaji A, Hicks J, Meeker A, Platz EA, De Marzo AM, Netto GJ. Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas. Am J Surg Pathol 2011; Jul;35(7):1014-20.
  102. Buadi F, Hsing AW, Katzmann JA, Pfeiffer RM, Waxman A, Yeboah ED, Biritwum RB, Tettey Y, Adjei A, Chu LW, Demarzo A, Netto GJ, Dispenzieri A, Kyle RA, Rajkumar SV, Landgren O. High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa. Am J Hematol 2011 Jul;86(7):554-8.
  103. Chaux A, Eifler J, Karram S, Al-Hussain T, Faraj S, Pomper M, Rodriguez R, Netto GJ. Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: Implications for novel intraoperative PSMA-based fluorescent imaging techniques. Urol Oncol  2011; Jun 1. [Epub ahead of print]
  104. Bruno TC, Rothwell C, Grosso JF, Getnet D, Yen HR, Durham NM, Netto G, Pardoll DM, Drake CG. Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model. Prostate. 2012 Apr;72(5):514-22. doi:10.1002/pros.21453. Epub 2011 Jul 14. PubMed PMID: 21761425; PubMed Central
  105. Toubaji A, Albadine R, Meeker AK, Isaacs WB, Lotan T, Haffner MC, Chaux A, Epstein JI, Han M, Walsh PC, Partin AW, De Marzo AM, Platz EA, Netto GJ. Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas. Mod Pathol 2011; Nov;24(11):1511-20.
  106. Lee TK, Chaux A, Karram S, Miyamoto H, Miller JS, Fajardo DA, Epstein JI, Netto GJ. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center. Hum Pathol 2011; Nov;42(11):1799-803.
  107. Albadine R, Hyndman ME, Chaux A, Jeong JY, Saab S, Tavora F, Epstein JI, Gonzalgo ML, Pavlovich CP, Netto GJ. Characteristics of positive surgical margins in robotic assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center. Hum Pathol. 2012 Feb;43(2):254-60. Epub 2011 Aug 4.PubMed PMID: 21820147.
  108. Chaux A, Karram S, Miller JS, Fajardo DA, Lee TK, Miyamoto H, Netto GJ. High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification cohort from a single academic center. Hum Pathol 2012; Jan;43(1):115-20.
  109. Schultz L, Chaux A, Albadine R, Hicks J, Kim JJ, De Marzo AM, Allaf ME, Carducci MA, Rodriguez R, Hammers H, Argani P, Reuter VE, Netto GJ. Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas. Am J Surg Pathol 2011; Oct;35(10):1549-56.
  110. Miyamoto H,Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing1 EM, Netto GJ, Yeh S. Expression of androgen and estrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int. 2012 Jun;109(11):1716-26. doi: 10.1111/j.1464-410X.2011.10706.x. Epub 2012 Jan 5. PubMed PMID: 22221549.
  111. Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, Toubaji A, Argani P, Iacobuzio-Donahue C, Nelson WG, Netto GJ, De Marzo AM, Yegnasubramanian S. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011; Aug;2(8):627-37.
  112. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih IM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, Taube JM, Rakheja D, Kurman RJ, Wu TC, Roden RB, Argani P, De Marzo AM, Terracciano L, Torbenson M, Meeker AK. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 2011; Oct;179(4):1608-15.
  113. Lotan T, Gurel B, Sutcliffe S, Esopi D, Liu W, Xu J, Hicks J, Park B, Humphreys E, Partin A, Han M, Netto GJ, Isaacs WB, De Marzo AM. PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients. Clin Cancer Res 2011; Oct 15;17(20):6453-73.
  114. Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, Millis M, Jennings LW, Fasola CG. A randomized multicenter study comparing steroid-free and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl 2011; Dec;17(12):1394-403.
  115. Karram S, Trock BJ, Netto GJ, Epstein JI. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings. Am J Surg Pathol 2011; Sep;35(9):1351-5.
  116. Karafin M, Parwani AV, Netto GJ, Illei PB, Epstein JI, Ladanyi M, Argani P. Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: evidence supporting renal tubular differentiation. Am J Surg Pathol 2011 Sep;35(9):1264-73.
  117. Brait M, Malonado L, Begum s, Loyo M, Wehle D, Tavora FF, Looijenga LH, Kowalski J, Zhang Z, Rosenbaum E, Halachmi S, Netto GJ, Hoque MO. DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma. Br J Cancer 2011; Nov 8. Doi:10.1038/bjc.2011.468.
  118. Chaux A, Netto GJ, Rodriquez IM, Barreto JE, Oertell J, Ocampos S, Boggino H, Codas R, Zavier Bosch F, de Sanjose S. Munoz N, Hildesheim A, Cubilla AL. Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol 2011; Nov 25 [Epub ahead of print]
  119. Chaux A, Velazquez EF, Amin A, Soskin A, Pfannl R, Rodriguez IM, Barreto JE, Lezcano C, Ayala G, Netto GJ, Cubilla AL. Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: a pathological study of 139 lesions in 121 patients. Hum Pathol. 2012 Jul;43(7):1020-7. Epub 2011 Dec 12. PubMed PMID: 22169255.
  120. Chaux A, Fajardo DA, Gonzalez-Roibon N, Partin AW, Eisenberger M, Deweese TL, Netto GJ. High-grade adenocarcinoma present in a single biopsy core as associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy. Urology 2011;79(4):863-8. PubMed PMID: 22173174; PubMed Central PMCID: PMC3449144.
  121. Woo SR, Turnis ME, Goldberg MV, Bankoti J, Selby M, Nirschl CJ, Bettini ML, Gravano DM, Vogel P, Liu CL, Tangsombatvisit S, Grosso JF, Netto G, Smeltzer MP, Chaux A, Utz PJ, Workman CJ, Pardoll DM, Korman AJ, Drake CG, Vignali DA. Immune infibitory molecules LAG-3 and PD-1 synergistically regulate Tcell function to promote tumoral immune escape. Cancer Res. 2012 Feb 15;72(4):917-27. Epub 2011Dec 20. PubMed PMID: 22186141; PubMed Central PMCID: PMC3288154.
  122. Vaughn MP, Biswal Shinohara D, Castagna N, Hicks JL, Netto G, De Marzo AM, Speed TJ, Reichert ZR, Kwabi-Addo B, Henderson CJ, Wolf CR, Yegnasubramanian S,Nelson WG. Humanizing π-class glutathione S-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdose. PLoS One. 2011;6(10):e25707. Epub 2011 Oct 11. PubMed PMID: 22022436; PubMed Central PMCID: PMC3191143.
  123. Chokkalingam AP, Yeboah ED, Demarzo A, Netto G, Yu K, Biritwum RB, Tettey Y, Adjei A, Jadallah S, Li Y, Chu LW, Chia D, Niwa S, Partin A, Thompson IM, Roehrborn C, Hoover RN, Hsing AW. Prevalence of BPH and lower urinary tract symptoms in West Africans. Prostate Cancer Prostatic Dis. 2012 Jun;15(2):170-6. doi: 10.1038/pcan.2011.43. Epub 2011 Sep 13. PubMed PMID: 21912428.
  124. Sher L, Jennings L, Rudich S, Alexopoulos SP, Netto G, Teperman L, Kinkhabwala M, Brown RS Jr, Pomfret E, Klintmalm G; HCV-3 Study Group. Results of live donor liver transplantation in patients with hepatitic C virus infection: the HCV 3 trial experience. Clin Transplant. 2012 May;26(3):502-9. doi: 10.1111/j.1399-0012.2011.01561.x. Epub 2011 Dec 12. PubMed PMID: 22151078.
  125.  Malinowska I, Kwiatkowski DJ, Weiss S, Martignoni G, Netto G, Argani P. Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am J Surg Pathol. 2012 May;36(5):783-4. PubMed PMID: 22456611; PubMed Central PMCID: PMC3327756.
  126. Chaux A, Cohen JS, Schultz L, Albadine R, Jadallah S, Murphy KM, Sharma R, Schoenberg MP, Netto GJ. High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues. Hum Pathol. 2012; 43(10):1590-5.PubMed PMID: 22406363.
  127. Rodriguez E, Netto G, Li QK. Intrapancreatic accessory spleen: A case report and review of literature. Diagn Cytopathol. 2012 Jan 12. doi: 10.1002/dc.22813.[Epub ahead of print] PubMed PMID: 22241738.
  128. Zheng G, Chaux A, Sharma R, Netto G, Caturegli P. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma. Exp Mol Pathol. 2012 Jun 12. [Epub ahead of print] PubMed PMID: 22705098.
  129. Chaux A, Brimo F, Gonzalez-Roibon N, Shah S, Schultz L, Rizk JM, Argani P, Hicks J, Netto GJ. Immunohistochemical Evidence of Dysregulation of the Mammalian Target of Rapamycin Pathway in Primary and Metastatic Pheochromocytomas. Urology.2012;80(3):736.e7-12 PubMed PMID: 22698476.
  130. Chaux A, Peskoe SB, Gonzalez-Roibon N, Schultz L, Albadine R, Hicks J, De Marzo AM, Platz EA, Netto GJ. Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer. Mod Pathol. 2012 Nov;25(11):1543-9.PubMed PMID: 22684219.
  131. Miyamoto H, Izumi K, Yao JL, Li Y, Yang Q, McMahon LA, Gonzalez-Roibon N, Hicks DG, Tacha D, Netto GJ. GATA binding protein 3 is down-regulated in bladder  cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor. Hum Pathol. 2012 Nov;43(11):2033-PubMed PMID: 22607700.
  132. Toubaji A, Sutcliffe S, Chaux A, Lecksell K, Hicks J, De Marzo AM, Platz EA,Netto GJ. Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases. Hum Pathol. 2012 ;43(11):1852-65 PubMed PMID: 22554381.
  133. Chaux A, Schultz L, Albadine R, Hicks J, Kim JJ, Allaf ME, Carducci MA, Rodriguez R, Hammers HJ, Argani P, Reuter VE, Netto GJ. Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas. Hum Pathol. 2012 Apr 26. [Epub ahead of print] PubMed PMID: 22542128.
  134.   Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL, Netto GJ, Miyamoto H. Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen. Mol Carcinog. 2012 Nov 9[Epub ahead of print] PubMed PMID: 23143693.

  135.     Sidana A, Wang M, Shabbeer S, Chowdhury WH, Netto G, Lupold SE, Carducci M, Rodriguez R. Mechanism of growth inhibition of prostate cancer xenografts by valproic Acid. J Biomed Biotechnol. 2012;2012:180363. doi: 10.1155/2012/180363. Epub 2012 Oct 2. PubMed PMID: 23093837; PubMed Central PMCID: PMC3471003.
  136.  Gonzalez-Roibon ND, Chaux A, Al-Hussain T, Osunkoya AO, Bezerra SM, Hicks J, Epstein JI, Netto GJ. Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder. Hum Pathol. 2012 Oct 17. doi:pii: S0046-8177(12)00265-1. 10.1016/j.humpath.2012.07.009. [Epub ahead of print] PubMed PMID: 23084634.
  137.  Georgiades C, Rodriguez R, Azene E, Weiss C, Chaux A, Gonzalez-Roibon N, Netto G. Determination of the Nonlethal Margin Inside the Visible "Ice-Ball" During Percutaneous Cryoablation of Renal Tissue. Cardiovasc Intervent Radiol. 2012 Aug 30. [Epub ahead of print] PubMed PMID: 22933102.
  138.  Argani P, Yonescu R, Morsberger L, Morris K, Netto GJ, Smith N, Gonzalez N, Illei PB, Ladanyi M, Griffin CA. Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol. 2012 Oct;36(10):1516-26.  PubMed PMID: 22892601.
  139.  Chaux A, Compérat E, Varinot J, Hicks J, Lecksell K, Solus J, Netto GJ. High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pT1 urothelial carcinoma of the bladder: a tissue microarray study of 156 patients treated by transurethral resection. Urology. 2013 Jan;81(1):116-22. PubMed PMID: 23273076
  140.  Gonzalez-Roibon N, Katz B, Chaux A, Sharma R, Munari E, Faraj SF, Illei PB,Torbenson M, Netto GJ. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. Hum Pathol. 2013 Jan 21.[Epub ahead of print] PubMed PMID: 23347651.
  141.  Zheng G, Martignoni G, Antonescu C, Montgomery E, Eberhart C, Netto G, Taube J, Westra W, Epstein JI, Lotan T, Maitra A, Gabrielson E, Torbenson M,Iacobuzio-Donahue C, Demarzo A, Shih IeM, Illei P, Wu TC, Argani P. A broad survey of cathepsin K immunoreactivity in human neoplasms. Am J Clin Pathol. 2013, Feb;139(2):151-159. PubMed PMID: 23355199.
  142.  Brait M, Munari E, Lebron C, Noordhuis MG, Begum S, Michailidi C, Gonzalez-Roibon N, Maldonado L, Sen T, Guerrero-Preston R, Cope L, Parrella P, Fazio VM, Ha PK, Netto GJ, Sidransky D, Hoque MO. Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma. Cell Cycle. 2013 Feb 22;12(7). [Epub ahead of print] PubMed PMID:23435205.
  143.  Chaux A, Cubilla AL, Haffner MC, Lecksell KL, Sharma R, Burnett AL, Netto GJ. Combining routine morphology, p16(INK4a) immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analyses. Urol Oncol. 2013 Mar 13. doi:pii: S1078-1439(12)00158-5.10.1016/j.urolonc.2012.04.017. [Epub ahead of print] PubMed PMID: 23499169.
  144.  Wada S, Jackson CM, Yoshimura K, Yen HR, Getnet D, Harris TJ, Goldberg MV,Bruno TC, Grosso JF, Durham N, Netto GJ, Pardoll DM, Drake CG. Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer. J Transl Med. 2013 Apr 4;11(1):89. [Epub ahead of print] PubMed PMID: 23557194.
  145.  Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.Proc Natl Acad Sci U S A. 2013 Mar 25. [Epub ahead of print] PubMed PMID:23530248.
  146.  Chaux A, Han JS, Lee S, Gonzalez-Roibon N, Sharma R, Burnett AL, Cubilla AL, Netto GJ. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra. Hum Pathol. 2013 Oct 14. doi:pii: S0046-8177(13)00312-2. 10.1016/j.humpath.2013.07.023. [Epub ahead of print] PubMed PMID: 24134931.
  147.  Chalfin HJ, Gurda GT, Hammers HJ, Netto GJ, Bivalacqua TJ. Renal cell carcinoma presenting with brain metastasis from a 1.6 cm primary tumor. Can J Urol. 2013 Oct;20(5):6965-7. PubMed PMID: 24128841.
  148.     Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, Navai N, Siefker-Radtke A, Phillips JJ, Robinson BD, Rubin MA, Volkmer B, Hautmann R, Küfer R, Hogendoorn PC, Netto G, Theodorescu D, James CD, Czerniak B, Miettinen M, Waldman T. Frequent truncating mutations of STAG2 in bladder cancer. Nat Genet. 2013 Oct 13. doi: 10.1038/ng.2800. [Epub ahead of print] PubMed PMID: 24121789.
  149.     Papadopoulos N, Kinde I, Munari E, Faraj SF, Hruban RH, Schoenberg MP, Bivalacqua T, Allaf ME, Springer S, Wang Y, Diaz LA Jr, Kinzler KW, Vogelstein B, Netto GJ. TERT Promoter Mutations Occur Early in Urothelial Neoplasia and are Biomarkers of Early Disease and Disease Recurrence in Urine. Cancer Res. 2013 Oct 11. [Epub ahead of print] PubMed PMID: 24121487.
  150. Darshan M, Zheng Q, Fedor HL, Wyhs N, Yegnasubramanian S, Lee P, Melamed J, Netto GJ, Trock BJ, De Marzo AM, Sfanos KS. Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network. Prostate. 2013 Sep 21. doi: 10.1002/pros.22730. [Epub ahead of print] PubMed PMID: 24115205.
  151. Chaux A, Munari E, Katz B, Sharma R, Lecksell K, Cubilla AL, Burnett AL, Netto             GJ. The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases. Hum Pathol. 2013 Sep 25. doi:pii: S0046-8177(13)00299-2. 10.1016/j.humpath.2013.07.012. [Epub ahead of print] PubMed PMID: 24075601.
  152. Munari E, Fujita K, Faraj S, Chaux A, Gonzalez-Roibon N, Hicks J, Meeker A, Nonomura N, Netto GJ. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma. Hum Pathol. 2013 Sep 27. doi:pii: S0046-8177(13)00295-5. 10.1016/j.humpath.2013.07.008. [Epub ahead of print] PubMed PMID: 24074531.
  153. Gonzalez-Roibon N, Albadine R, Sharma R, Faraj SF, Illei PB, Argani P, Ertoy D, Allaf ME, Netto GJ. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas. Hum Pathol. 2013 Sep 24. doi:pii: S0046-8177(13)00293-1. 10.1016/j.humpath.2013.07.006. [Epub ahead of print] PubMed PMID: 24071011.
  154. Gurda GT, Vandenbussche CJ, Yonescu R, Gonzalez-Roibon N, Ellis CL, Batista DA, Netto GJ. Sacrococcygeal teratomas: clinico-pathological characteristics and isochromosome 12p status. Mod Pathol. 2013 Sep 20. doi: 10.1038/modpathol.2013.171. [Epub ahead of print] PubMed PMID: 24051698.
  155. Faraj SF, Albadine R, Chaux A, Gonzalez-Roibon N, Hicks J, Humphreys E, Partin A, Netto GJ. Activation of Mammalian Target of Rapamycin Signaling Pathway Markers in Minute Adenocarcinoma of the Prostate. Urology. 2013 Sep 11. doi:pii: S0090-4295(13)00893-5. 10.1016/j.urology.2013.07.028. [Epub ahead of print] PubMed PMID: 24035134.
  156. Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R, Egevad L, Srigley JR, Delahunt B, Moch H; ISUP Renal Tumor Panel. Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol. 2013 Oct;37(10):1518-31. doi: 10.1097/PAS.0b013e318299f12e. PubMed PMID: 24025522.
  157. Chaux A, Albadine R, Schultz L, Hicks J, Carducci MA, Argani P, Allaf M, Netto GJ. Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas. Hum Pathol. 2013 Oct;44(10):2323-30. doi: 10.1016/j.humpath.2013.05.014. Epub 2013 Aug 15. PubMed PMID: 23953228.

  158. Green WM, Yonescu R, Morsberger L, Morris K, Netto GJ, Epstein JI, Illei PB, Allaf M, Ladanyi M, Griffin CA, Argani P. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae. PubMed PMID: 23715164.
  159. Fahmy M, Mansure JJ, Brimo F, Yafi FA, Segal R, Althunayan A, Hicks J, Meeker A, Netto G, Kassouf W. Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer. Hum Pathol. 2013 Sep;44(9):1766-72. PubMed PMID: 23623586.
  160. González-Roibón N, Han JS, Lee S, Feng Z, Arslankoz S, Smith N, Pierorazio PM, Humphreys E, Deweese TL, Partin AW, Bivalacqua TJ, Han M, Trock B, Netto GJ. Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancer. Int J Surg Pathol. 2013 Aug;21(4):352-7. PubMed PMID:23564700.
  161. Raman SP, Johnson PT, Allaf ME, Netto G, Fishman EK. Chromophobe renal cell carcinoma: multiphase MDCT enhancement patterns and morphologic features. AJR Am J Roentgenol. 2013 Dec;201(6):1268-76. doi: 10.2214/AJR.13.10813. PubMed PMID: 24261366.
  162. Ellis CL, Eble JN, Subhawong AP, Martignoni G, Zhong M, Ladanyi M, Epstein JI, Netto GJ, Argani P. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. Mod Pathol. 2014 Jun;27(6):875-86. doi: 10.1038/modpathol.2013.208. Epub 2013 Dec 6. PubMed PMID: 24309327.
  163. Gonzalez-Roibon N, Faraj SF, Munari E, Bezerra SM, Albadine R, Sharma R, Argani P, Allaf ME, Netto GJ. Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms. Hum Pathol. 2014 Feb;45(2):244-8. doi: 10.1016/j.humpath.2013.08.020. Epub 2013 Dec 4. PubMed PMID: 24315206.
  164. Tan HL, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, Mosier S, Gocke CD, Epstein JI, Netto GJ, Liu W, Isaacs WB, De Marzo AM, Lotan TL. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin Cancer Res. 2014 Feb 15;20(4):890-903. doi: 10.1158/1078-0432.CCR-13-1982. Epub 2013 Dec 9. PubMed PMID: 24323898; PubMed Central PMCID: PMC3931005.  
  165. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong SM, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih lM, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang TL, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz LA Jr. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014 Feb 19;6(224):224ra24. doi: 10.1126/scitranslmed.3007094. PubMed PMID: 24553385; PubMed Central PMCID: PMC4017867.
  166. Rodić N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, Goggins M, Shih IeM, Duffield AS, Montgomery EA, Gabrielson E, Netto GJ, Lotan TL, De Marzo AM, Westra W, Binder ZA, Orr BA, Gallia GL, Eberhart CG, Boeke JD, Harris CR, Burns KH. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol. 2014 May;184(5):1280-6. doi: 10.1016/j.ajpath.2014.01.007. Epub 2014 Mar 6. PubMed PMID: 24607009; PubMed Central PMCID: PMC4005969.

  167.   Chaux A, Munari E, Cubilla AL, Hicks J, Lecksell K, Burnett AL, Netto GJ. Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Histopathology. 2014 May;64(6):863-71. doi: 10.1111/his.12338. Epub 2014 Feb 24. PubMed PMID: 24279699.
  168. Smith NE, Illei PB, Allaf M, Gonzalez N, Morris K, Hicks J, Demarzo A, Reuter VE, Amin MB, Epstein JI, Netto GJ, Argani P. t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases. Am J Surg Pathol. 2014 May;38(5):604-14. doi: 10.1097/PAS.0000000000000203. PubMed PMID: 24618616.
  169.   Smith NE, Deyrup AT, Mariño-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P. VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Am J Surg Pathol. 2014 Jun;38(6):858-63. doi: 10.1097/PAS.0000000000000179. PubMed PMID: 24698962
  170.   Munari E, Marchionni L, Chitre A, Hayashi M, Martignoni G, Brunelli M, Gobbo S, Argani P, Allaf M, Hoque MO, Netto GJ. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Hum Pathol. 2014 Jun;45(6):1130-8. doi: 10.1016/j.humpath.2014.01.013. Epub 2014 Jan 31. PubMed PMID: 24703100.
  171. Gonzalez-Roibon N, Kim JJ, Faraj SF, Chaux A, Bezerra SM, Munari E, Ellis C, Sharma R, Keizman D, Bivalacqua TJ, Schoenberg M, Eisenberger M, Carducci M, Netto GJ. Insulin-like Growth Factor-1 Receptor Overexpression Is Associated With Outcome in Invasive Urothelial Carcinoma of Urinary Bladder: A Retrospective Study of Patients Treated Using Radical Cystectomy. Urology. 2014 Jun;83(6):1444.e1-6. doi: 10.1016/j.urology.2014.01.028. Epub 2014 Apr 6. PubMed PMID: 24713135.
  172. Hsing AW, Yeboah E, Biritwum R, Tettey Y, De Marzo AM, Adjei A, Netto GJ, Yu K, Li Y, Chokkalingam AP, Chu LW, Chia D, Partin A, Thompson IM, Quraishi SM, Niwa S, Tarone R, Hoover RN. High Prevalence of Screen Detected Prostate Cancer in West Africans: Implications for Racial Disparity of Prostate Cancer. J Urol. 2014 Apr 18. pii: S0022-5347(14)03345-X. doi: 10.1016/j.juro.2014.04.017. [Epub ahead of print] PubMed PMID: 24747091.
  173. Maldonado L, Brait M, Loyo M, Sullenberger L, Wang K, Peskoe SB, Rosenbaum E, Howard R, Toubaji A, Albadine R, Netto GJ, Hoque MO, Platz EA, Sidransky D. GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer. J Urol. 2014 Apr 21. pii: S0022-5347(14)03413-2. doi: 10.1016/j.juro.2014.04.082. [Epub ahead of print] PubMed PMID: 24769028.
  174. Chung CC, Hsing AW, Edward Yeboah, Biritwum R, Tettey Y, Adjei A, Cook MB, De Marzo A, Netto G, Tay E, Boland JF, Yeager M, Chanock SJ. A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry. Prostate. 2014 May;74(6):579-89. PubMed PMID: 24783269.
  175. Hayashi M, Bernert H, Kagohara LT, Maldonado L, Brait M, Schoenberg M, Bivalacqua T, Netto GJ, Koch W, Sidransky D, Hoque MO. Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine. Oncotarget. 2014 May 30;5(10):3350-61. PubMed PMID: 24830820.
  176. Bezerra SM, Lotan TL, Faraj SF, Karram S, Sharma R, Schoenberg M, Bivalacqua TJ, Netto GJ. GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin. Hum Pathol. 2014 Apr 24. pii: S0046-8177(14)00164-6. doi: 10.1016/j.humpath.2014.04.011. [Epub ahead of print] PubMed PMID: 24925221.
  177. Arora V, Schwartz G, Tilson MP, Netto GJ, Mandal K. A Right Atrial Mass: "More Than Meets the Eye". J Clin Oncol. 2014 Jun 23. pii: JCO.2013.49.3130. [Epub ahead of print] PubMed PMID: 24958822
  178. Ball MW, Bezerra SM, Gorin MA, Cowan M, Pavlovich CP, Pierorazio PM, Netto GJ, Allaf ME. Grade Heterogeneity in Small Renal Masses: Potential Implications for Renal Mass Biopsy. J Urol. 2014 Jun 21. pii: S0022-5347(14)03826-9. doi:10.1016/j.juro.2014.06.067. [Epub ahead of print] PubMed PMID: 24960470.
  179. Reese AC, Ball MW, Gandhi N, Gorin MA, Netto GJ, Bivalacqua TJ, Schoenberg MP. The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer. Urology. 2014 Aug;84(2):358-63. doi: 10.1016/j.urology.2014.03.040. PubMed PMID: 25065987.181.           
  180. Brennen WN, Rosen DM, Chaux A, Netto GJ, Isaacs JT, Denmeade SR. Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-activated prodrug in murine xenograft models of human cancer. Prostate. 2014 Sep;74(13):1308-19. doi: 10.1002/pros.22847. Epub 2014 Jul 22. PubMed PMID: 25053236; PubMed Central PMCID: PMC4130904.
  181. Munari E, Chaux A, Maldonado L, Compérat E, Varinot J, Bivalacqua TJ, Hoque MO, Netto GJ. Cyclin A1 Expression Predicts Progression in pT1 Urothelial Carcinoma of Bladder: A Tissue Microarray Study of 149 Patients Treated by Transurethral Resection. Histopathology. 2015 Jan;66(2):262-9. doi: 10.1111/his.12499. Epub 2015 Jan 7. PubMed PMID: 25039670
  182. Reese AC, Johnson PT, Gorin MA, Pierorazio PM, Allaf ME, Fishman EK, Netto GJ, Pavlovich CP. Pathological characteristics and radiographic correlates of complex renal cysts. Urol Oncol. 2014 Oct;32(7):1010-6. doi: 10.1016/j.urolonc.2014.02.022. PubMed PMID: 25022857.
  183. Ishiguro H, Kawahara T, Zheng Y, Netto GJ, Miyamoto H. Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression. Am J Clin Pathol. 2014 Aug;142(2):157-64. doi: 10.1309/AJCPU8UCEZYG4WTV. PubMed PMID: 25015855.
  184. Maldonado L, Brait M, Michailidi C, Munari E, Driscoll T, Schultz L, Bivalacqua T, Schoenberg M, Sidransky D, Netto GJ, Hoque MO. An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine. Oncotarget. 2014 Jun 23. [Epub ahead of print] PubMed PMID: 24980822.
  185. Zheng X, Zhuge J, Bezerra SM, Faraj SF, Munari E, Fallon JT, Yang XJ, Argani P, Netto GJ, Zhong M. High Frequency of TERT mutations in Small Cell Carcinoma of Bladder. J Hematol Oncol. 2014 Jul 20;7:47. doi: 10.1186/s13045-014-0047-7. PubMed PMID: 25042800; PubMed Central PMCID: PMC4223615.
  186. Bezerra SM, Chaux A, Ball MW, Faraj SF, Munari E, Gonzalez-Roibon N, Sharma R, Bivalacqua TJ, Burnett AL, Netto GJ. Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas. Hum Pathol. 2014 Dec 31. pii: S0046-8177(14)00511-5. doi: 10.1016/j.humpath.2014.12.004. [Epub ahead of print] PubMed PMID: 25661481.
  187. Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1. Oncotarget. 2015 Jan 8. [Epub ahead of print] PubMed PMID: 25638160.
  188. Kawahara T, Kashiwagi E, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis. Mol Carcinog. 2015 Jan 15. doi: 10.1002/mc.22265. [Epub ahead of print] PubMed PMID: 25594762.
  189. Michailidi C, Hayashi M, Datta S, Sen T, Zenner K, Oladeru O, Brait M, Izumchenko E, Baras A, VandenBussche C, Argos M, Bivalacqua TJ, Ahsan H, Hahn NM, Netto GJ, Sidransky D, Hoque MO. Involvement of epigenetics and EMT related miRNA in arsenic induced neoplastic transformation and their potential clinical use. Cancer Prev Res (Phila). 2015 Jan 13. pii: canprevres.0251.2014. [Epub ahead of print] PubMed PMID: 25586904.
  190. Rioux-Leclercq N, Ferran A, Mahul A, Argani P, Billis A, Bonsib S, Cheng L, Cheville J, Eble J, Egevad L, Epstein J, Grignon D, Hes O, Humphrey P, Magi-Galluzzi C, Martignoni G, McKenney J, Merino M, Moch H, Montironi R, Netto             G, Reuter V, Samaratunga H, Shen S, Srigley J, Tamboli P, Tan PH, Tickoo S, Trpkov K, Zhou M, Delahunt B, Comperat E. [Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations]. Ann Pathol. 2014 Dec;34(6):448-61. doi: 10.1016/j.annpat.2014.10.003. Epub 2014 Nov 18. French. PubMed PMID: 25499860.
  191. Tian W, Guner G, Miyamoto H, Cimino-Mathews A, Gonzalez-Roibon N, Argani P, Li X, Sharma R, Subhawong AP, Rezaei K, Bivalacqua TJ, Epstein JI, Bishop JA, Netto             GJ. Utility of uroplakin II expression as a marker of urothelial carcinoma. Hum Pathol. 2015 Jan;46(1):58-64. doi: 10.1016/j.humpath.2014.09.007. Epub 2014 Oct 2. PubMed PMID: 25449628.
  192. McNeil BK, Sorbellini M, Grubb RL 3rd, Apolo A, Cecchi F, Athauda G, Cohen B, Giubellino A, Simpson H, Agarwal PK, Coleman J, Getzenberg RH, Netto GJ, Shih J, Linehan WM, Pinto PA, Bottaro DP. Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder. J Transl Med. 2014 Oct 21;12:199. doi: 10.1186/1479-5876-12-199. PubMed PMID: 25335552; PubMed Central PMCID: PMC4283116.
  193. Argani P, Lewin JR, Edmonds P, Netto GJ, Prieto-Granada C, Zhang L, Jungbluth AA, Antonescu CR. Primary Renal Sclerosing Epithelioid Fibrosarcoma: Report of 2 Cases With EWSR1-CREB3L1 Gene Fusion. Am J Surg Pathol. 2015 Mar;39(3):365-373. PubMed PMID: 25353281.
  194. Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ, Tsai YC, Muyan M, Wu XR, Messing EM, Guancial EA, Yeh S. Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo. Oncotarget. 2014 Sep 15;5(17):7917-35. PubMed PMID: 25277204; PubMed Central PMCID: PMC4202170.
  195. Banet N, Gown AM, Shih IeM, Kay Li Q, Roden RB, Nucci MR, Cheng L, Przybycin CG, Nasseri-Nik N, Wu LS, Netto GJ, Ronnett BM, Vang R. GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility. Am J Surg Pathol. 2015 Jan;39(1):101-8. PubMed PMID: 25188865; PubMed Central PMCID: PMC4268033.
  196. Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Ellis C, Driscoll T, Schoenberg MP, Bivalacqua TJ, Shih IeM, Netto GJ. ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder. Hum Pathol. 2014 Nov;45(11):2233-9. doi: 10.1016/j.humpath.2014.07.003. Epub 2014 Jul 23. PubMed PMID: 25175170.
  197. Amin MB, Smith SC, Reuter VE, Epstein JI, Grignon DJ, Hansel DE, Lin O, McKenney JK, Montironi R, Paner GP, Al-Ahmadie HA, Algaba F, Ali S, Alvarado-Cabrero I, Bubendorf L, Cheng L, Cheville JC, Kristiansen G, Cote RJ, Delahunt B, Eble JN, Genega EM, Gulmann C, Hartmann A, Langner C, Lopez-Beltran A, Magi-Galluzzi C, Merce J, Netto GJ, Oliva E, Rao P, Ro JY, Srigley JR, Tickoo SK, Tsuzuki T, Umar SA, Van der Kwast T, Young RH, Soloway MS. Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Mod Pathol. 2014 Nov 21. doi: 10.1038/modpathol.2014.158. [Epub ahead of print]. PubMed PMID: 25412849.
  198. Gandhi NM, Baras A, Munari E, Faraj S, Reis LO, Liu JJ, Kates M, Hoque M,Berman D, Hahn NM, Eisenberger M, Netto GJ, Schoenberg MP, Bivalacqua TJ.Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes. Urol Oncol. 2015 Mar 23.pii: S1078-1439(15)00072-1. doi:10.1016/j.urolonc.2015.02.011. [Epub ahead ofprint] PubMed PMID: 25814145.
  199. Faraj SF, Munari E, Guner G, Taube J, Anders R, Hicks J, Meeker A, Schoenberg M, Bivalacqua T, Drake C, Netto GJ. Assessment of Tumoral PD-L1 Expression and Intratumoral CD8+ T Cells in Urothelial Carcinoma. Urology. 2015 Mar;85(3):703.e1-6. doi: 10.1016/j.urology.2014.10.020. PubMed PMID: 25733301.

  200. Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Cubilla AL, Shih IeM,             Netto GJ. Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Hum Pathol. 2015 May;46(5):761-6. doi: 10.1016/j.humpath.2015.01.018. Epub 2015 Feb 12. PubMed PMID: 25776029.
  201. Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, Guner G, Munari E, Partin AW, Pavlovich CP, Han M, Carter HB, Bivalacqua TJ, Blackford A, Holt D, Dannals RF, Netto GJ, Lodge MA, Mease RC, Pomper MG, Cho SY. 18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer. J Nucl Med. 2015 Jul;56(7):1003-10. doi: 10.2967/jnumed.115.154336. Epub 2015 Jun 11. PubMed PMID: 26069305
  202. Ross AE, Johnson MH, Yousefi K, Davicioni E, Netto GJ, Marchionni L, Fedor HL, Glavaris S, Choeurng V, Buerki C, Erho N, Lam LL, Humphreys EB, Faraj S, Bezerra SM, Han M, Partin AW, Trock BJ, Schaeffer EM. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men. Eur Urol. 2015 Jun 6. pii: S0302-2838(15)00444-3. doi: 10.1016/j.eururo.2015.05.042. [Epub ahead of print] PubMed PMID: 26058959.
  203. Smith NE, Epstein JI, Parwani AV, Netto GJ, Illei PB, Powell K, Allaf ME, Argani P. Smooth muscle and adenoma-like renal tumor: a previously unreported Variant of mixed epithelial stromal tumor or a distinctive renal neoplasm? Hum Pathol. 2015 Jun;46(6):894-905. doi: 10.1016/j.humpath.2015.02.003. Epub 2015 Feb 19. PubMed PMID: 25911262.
  204. Hurley PJ, Hughes RM, Simons B, Huang J, Miller RM, Shinder B, Haffner MC, Esopi D, Kinura Y, Jabbari J, Ross AE, Erho N, Vergara IA, Faraj SF, Davicioni E, Netto GJ, Yegnasubramanian S, An S, Schaeffer E. Androgen Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression. Cancer Res. 2015 Aug 20. pii: canres.0024.2015. [Epub ahead of print] PubMed PMID: 26294211.
  205. Tsai H, Morais CL, Alshalalfa M, Tan HL, Haddad Z, Hicks JL, Gupta N, Epstein JI, Netto GJ, Isaacs WB, Luo J, Mehra R, Vessella RL, Karnes RJ, Schaeffer E, Davicioni E, De Marzo AM, Lotan TL. Cyclin D1 Loss Distinguishes Prostatic Small Cell Carcinoma from Most Prostatic Adenocarcinomas. Clin Cancer Res. 2015 Aug 5. pii: clincanres.0744.2015. [Epub ahead of print] PubMed PMID: 26246306.
  206. Baras AS, Gandhi N, Munari E, Faraj S, Shultz L, Marchionni L, Schoenberg M, Hahn N, Hoque M, Berman D, Bivalacqua TJ, Netto G. Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma. PLoS One. 2015 Jul 31;10(7):e0131245. doi: 10.1371/journal.pone.0131245. eCollection 2015. PubMed PMID: 26230923; PubMed Central PMCID: PMC4521868.
  207. Morais CL, Herawi M, Toubaji A, Albadine R, Hicks J, Netto GJ, De Marzo AM, Epstein JI, Lotan TL. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas. Prostate. 2015 Oct;75(14):1610-9. doi: 10.1002/pros.23042. Epub 2015 Jul 14. PubMed PMID: 26178158; PubMed Central PMCID: PMC4537350.
  208. Ozluk Y, Taheri D, Matoso A, Sanli O, Berker NK, Yakirevich E, Balasubramanian S, Ross JS, Ali SM, Netto GJ. Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma. Hum Pathol. 2015 Sep 5. [Epub ahead of print] PubMed PMID: 26476567.
  209. Ball MW, Gorin MA, Harris KT, Curtiss KM, Netto GJ, Pavlovich CP, Pierorazio PM, Allaf ME. Extent of Renal Vein Invasion Influences Prognosis in Patients with Renal Cell Carcinoma. BJU Int. 2015 Oct 11. doi: 10.1111/bju.13349. [Epub ahead of print] PubMed PMID: 26456548.
  210. Hurley PJ, Sundi D, Shinder B, Simons B, Hughes RM, Miller RM, Benzon B, Faraj SF, Netto GJ, Vergara IA, Erho N, Davicioni E, Karnes RJ, Yan G, Ewing CM, Isaacs SD, Berman DM, Rider JR, Jordahl KM, Mucci LA, Huang J, An S, Park BH, Isaacs WB, Marchionni L, Ross AE, Schaeffer E. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment and are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res. 2015 Oct 7. pii: clincanres.0256.2015. [Epub ahead of print] PubMed PMID: 26446945.
  211. Luchini C, Veronese N, Solmi M, Cho H, Kim JH, Chou A, Gill AJ, Faraj SF, Chaux A, Netto GJ, Nakayama K, Kyo S, Lee SY, Kim DW, Yousef GM, Scorilas A, Nelson GS, Köbel M, Kalloger SE, Schaeffer DF, Yan HB, Liu F, Yokoyama Y, Zhang X, Pang D, Lichner Z, Sergi G, Manzato E, Capelli P, Wood LD, Scarpa A, Correll CU. Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. Oncotarget. 2015 Sep 8. [Epub ahead of print] PubMed PMID: 26384299.
  212. Kawahara T, Shareef HK, Aljarah AK, Ide H, Li Y, Kashiwagi E, Netto GJ, Zheng Y, Miyamoto H. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression. Oncotarget. 2015 Oct 6;6(30):29860-76. doi: 10.18632/oncotarget.5007. PubMed PMID: 26342199.
  213. Park JC, Gandhi NM, Carducci MA, Eisenberger MA, Baras AS, Netto GJ, Liu JJ,Drake CG, Schoenberg MP, Bivalacqua TJ, Hahn NM. A Retrospective Analysis of the Effect of Time from Diagnosis to Cystectomy on Survival in Patients with Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy. J Urol. 2015 Nov 17. pii: S0022-5347(15)05238-6. doi: 10.1016/j.juro.2015.11.024. [Epub ahead of print] PubMed PMID: 26598426.
  214. Reis LO, Taheri D, Chaux A, Guner G, Mendoza Rodriguez MA, Bivalacqua TJ,Schoenberg MP, Epstein JI, Netto GJ. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. Hum Pathol. 2015 Sep 25. pii: S0046-8177(15)00344-5. doi: 10.1016/j.humpath.2015.09.007. [Epub ahead of print] PubMed PMID: 26520419.
  215. Ozluk Y, Taheri D, Matoso A, Sanli O, Berker NK, Yakirevich E, Balasubramanian S, Ross JS, Ali SM, Netto GJ. Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma. Hum Pathol. 2015 Dec;46(12):1951-5. doi:10.1016/j.humpath.2015.07.027. Epub 2015 Sep 5. PubMed PMID: 26476567



  1. Prostate Biopsy Interpretation. JI Epstein, GJ Netto, 4th ed, Lippincott Williams & Wilkins, Philadelphia, 2007.
  2. High Yield Genitourinary Pathology. M Zhou M, GJ Netto, JI Epstein, Editors; Elsevier, 2012
  3. JI Epstein, GJ Netto: Differential Diagnosis in Surgical Pathology: Genitourinary System, Walters Kluwer Health, Baltimore, 2014
  4. Prostate Biopsy Interpretation. JI Epstein, GJ Netto, 5th ed, Lippincott Williams & Wilkins, Philadelphia, 2014.
  5. Genomic Applications in Pathology. GJ Netto and I Schrijver, Editors. Springers , 2014

Book Chapters

  1. Netto GJ. Pathology of liver transplantation: grading and staging systems. In Atlas of Liver Transplantation, Molmenti & Klintmalm, eds., Elsevier Science, Chapter 37, 2002.
  2. Netto GJ. Pathology of liver transplantation: recurrence of primary hepatic diseases in transplanted livers.  In Atlas of Liver Transplantation. Molmenti & Klintmalm, eds, Elsevier Science, Chap 36, 2002.
  3. Netto GJ. Pathology of liver transplantation: primary hepatic disease. In Atlas of Liver Transplantation. Molmenti & Klintmalm, eds, Elsevier Science, Chap35, 2002.
  4. Netto GJ. Tumors of unknown primary origin: the role of immunohistochemistry and molecular diagnostics. In American Society of Clinical Oncology 2002 Educational Book, Perry MC, ed., Lippincott Williams & Wilkins, Baltimore, 2002;343-7. 
  5. Hansel DE, Netto GJ, Montgomery EA, Epstein JI. Mesenchymal tumors of the prostate. In Surgical Pathology Clinics, Vol 1, Issue 1, WB Saunders, 2008.
  6. Netto GJ, Epstein JI. Benign Mimickers of prostate adenocarcinoma on needle biopsy and transurethral resection. In Surgical Pathology Clinics, Vol 1, Issue 1, WB Saunders, 2008.
  7. Netto GJ, Epstein JI. Immunohistology and molecular diagnostics of the prostate, urinary bladder, kidney and testis neoplasms. In Diagnostic Immunohistochemistry. Dabbs D, ed, Churchill Livingston Elsevier, 3rd ed, Chap 16; 2010.
  8. Epstein JI and Netto GJ: The prostate and Seminal Vesicle. In Sternberg’s diagnostic surgical pathology. Mills SE, ed. Lippincott Williams & Wilkins, 5th ed, 2010: Chap 45: 1871-1913.
  9. GJ Netto and Liang Cheng: Molecular Pathology of the Urinary Bladder. In Molecular Surgical Pathology. Liang Cheng and John N Eble eds Springer 2012: Chap11: 229-253
  10. GJ Netto: Molecular Pathology of Bladder Cancer. In Surgical Pathology Clinics Molecular Oncology. Jennifer L Hunt and John R Goldblum eds. Vol 5, Issue 4, Elsevier 2012
  11. GJ Netto and JI Epstein JI. Immunohistology of the Prostate. In Diagnostic Immunohistochemistry. Theranostic and Genomic Applications. David J Dabbs, ed, Elsevier, 4rd ed, Chap 16; 2014.
  12. GJ Netto and JI Epstein JI. Immunohistology of the Bladder, Kidney and Testis. In Diagnostic Immunohistochemistry. Theranostic and Genomic Applications. David J Dabbs, ed, Elsevier, 4rd ed, Chap 17; 2014.
  13. JI Epstein and Netto GJ: The prostate and Seminal Vesicle. In Sternberg’s diagnostic surgical pathology. Mills SE, ed. Lippincott Williams & Wilkins, 6th ed, 2015
  14. CS Foster and GJ Netto: Diseases of The Urinary Tract. In Silverberg's Principles and Practice of Surgical Pathology and Cytopathology, Wick, LiVolsi, Pfeifer, Stelow, & Wakely ed. Cambridge University Press 5th ed, 2015
  15. GJ Netto: Molecular Pathology of Prostate Cancer, An Update. In Surgical Pathology Clinics Molecular Oncology. Michelle Hirsch and John R Goldblum eds. , In Press
  16. GJ Netto: Urothelial Carcinoma Prognosis and Predictive factors: Genetic and Molecular Biomarkers. In World Health Organization (WHO) Classification of Tumours of the Urinary System and Male Genital Organs, 4th edition, Moch, Humphrey,Ulbright and Reuter. International Agency for Research on Cancer (IARC), Lyon cedex, France, In Press
  17. GJ Netto: Prostate Carcinoma: Etiology and Genetic Susceptibility. In World Health Organization (WHO) Classification of Tumours of the Urinary System and Male Genital Organs, 4th edition, Moch, Humphrey,Ulbright and Reuter. International Agency for Research on Cancer (IARC), Lyon cedex, France, In Press



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved. Disclaimer
Email: | 600 North Wolfe Street, Baltimore, Maryland 21287

urology second opinion urology second opinion